These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11769715)

  • 21. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
    Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synergism of an antisense oligodeoxynucleotides targeted to hTERT in combination with chemotherapeutic drugs on inhibiting the proliferation of HepG2 cells].
    Yang Y; Du QY; Wang SQ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):719-21. PubMed ID: 14697130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase is limiting the growth of acute myeloid leukemia cells.
    Röth A; Vercauteren S; Sutherland HJ; Lansdorp PM
    Leukemia; 2003 Dec; 17(12):2410-7. PubMed ID: 14562114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
    Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
    Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.
    Zinzani PL; Buzzi M; Farabegoli P; Martinelli G; Tosi P; Zuffa E; Visani G; Testoni N; Salvucci M; Bendandi M
    Haematologica; 1994; 79(2):127-31. PubMed ID: 8063259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1.
    Yamada O; Ozaki K; Furukawa T; Machida M; Wang YH; Motoji T; Mitsuishi T; Akiyama M; Yamada H; Kawauchi K; Matsuoka R
    Cell Signal; 2011 Jul; 23(7):1119-27. PubMed ID: 21356308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
    Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
    Kantarjian HM; Beran M; O'Brien S; Robertson L; Siddik Z; Yoshida M; Yang LY; Rios MB; Keating MJ; Meyer M
    Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
    Gao XD; Chen YR
    Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of antisense oligodeoxynucleotides of human telomerase reverse transcriptase gene on telomerase activity in CEM cell line].
    Li WY; Zhang Y; He DM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):450-3. PubMed ID: 14575534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
    Campbell LJ; Fidler C; Eagleton H; Peniket A; Kusec R; Gal S; Littlewood TJ; Wainscoat JS; Boultwood J
    Leukemia; 2006 Apr; 20(4):671-9. PubMed ID: 16498395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli.
    Holtz MS; Forman SJ; Bhatia R
    Leukemia; 2005 Jun; 19(6):1034-41. PubMed ID: 15815728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
    Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
    Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571.
    Tabrizi R; Mahon FX; Cony Makhoul P; Lagarde V; Lacombe F; Berthaud P; Melo JV; Reiffers J; Belloc F
    Leukemia; 2002 Jun; 16(6):1154-9. PubMed ID: 12040447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.
    Soupir CP; Vergilio JA; Dal Cin P; Muzikansky A; Kantarjian H; Jones D; Hasserjian RP
    Am J Clin Pathol; 2007 Apr; 127(4):642-50. PubMed ID: 17369142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
    Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells.
    Song G; Liao X; Zhou L; Wu L; Feng Y; Han ZC
    Leuk Res; 2004 Oct; 28(10):1089-96. PubMed ID: 15289023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.
    Mayerhofer M; Aichberger KJ; Florian S; Krauth MT; Hauswirth AW; Derdak S; Sperr WR; Esterbauer H; Wagner O; Marosi C; Pickl WF; Deininger M; Weisberg E; Druker BJ; Griffin JD; Sillaber C; Valent P
    FASEB J; 2005 Jun; 19(8):960-2. PubMed ID: 15784722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hTERT antisense oligodeoxynucleotide on cell apoptosis and expression of hTERT and bcl-2 mRNA in keloid fibroblasts.
    Huang Y; Lin LX; Bi QX; Wang P; Wang XM; Liu J; Wang YT
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1944-1951. PubMed ID: 28485781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.